Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Enhancing the accessibility of health data can lead to improved decision-making while reducing costs. Binah.ai offers an innovative health data platform that leverages AI and video technology, providing a software-only solution for various industries seeking immediate health metrics. Users can easily gather a diverse array of health parameters—including heart rate, heart rate variability (both HRV SDNN and raw RRI data), oxygen saturation, respiration rate, sympathetic stress, parasympathetic activity, and the pulse-respiration quotient (PRQ), with blood pressure measurements on the way. By eliminating the requirement for wearables or specialized hardware, Binah.ai’s platform, delivered as a software development kit (SDK), is compatible with numerous devices and operating systems. This enables effortless health and wellness tracking using personal electronic devices such as smartphones, tablets, or laptops that users already own, thus simplifying the process of health monitoring. Consequently, this approach empowers individuals to take charge of their health with minimal barriers.

Description

Introducing a versatile API designed to seamlessly integrate with your diabetes management system, offering tailored therapeutic education and enhanced insights into blood glucose level fluctuations. This solution enables real-time risk predictions, fostering greater personalization and improved system regulation, while adeptly managing complex living scenarios characterized by rapid glucose variations. With advancements in telemedicine and retrospective analysis, patients receive robust decision-support tools. Currently, Hillo is developing the next iterations of its AI technology, which includes a therapeutic recommendation system aimed at preventing hypoglycemia and hyperglycemia, anticipated to achieve CE mark class IIB by 2020. Additionally, a new generation of the artificial pancreas is projected for release in 2021, addressing key limitations of existing systems through ultra-personalization driven by machine learning. This innovative approach marks the introduction of the first self-learning artificial intelligence capable of predicting blood glucose levels, aiming to secure a CE mark as a medical device, thereby transforming diabetes management for users. In essence, Hillo's advancements could significantly enhance the quality of life for individuals managing diabetes.

API Access

Has API No 

API Access

Has API Yes 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial Yes 
Free Version No 

Pricing Details

No price information available.
Free Trial Yes 
Free Version No 

Deployment

Web-Based No 
On-Premises No 
iPhone App Yes 
iPad App Yes 
Android App Yes 
Windows Yes 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) Yes 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) No 
In Person Yes 

Vendor Details

Company Name

Binah.ai

Founded

2016

Country

Israel

Website

www.binah.ai/

Vendor Details

Company Name

Hillo

Country

France

Website

www.hillo.ai/

Product Features

Product Features

Alternatives

Fedo Reviews

Fedo

FEDO AI

Alternatives

Upvio Reviews

Upvio

Upvio Healthtech
Altis Labs Nota Reviews

Altis Labs Nota

Altis Labs